Griffon's Q3 Beat Solidifies Bull Case, Margin Resurgence and Simplification Progress Force Thesis Upgrade

What happened

Griffon Corporation reported upbeat fiscal third-quarter 2026 results, with single-digit revenue growth and healthy margin expansion, demonstrating that the Home and Building Products segment is recovering from the margin compression seen earlier in the year. The company’s strategic restructuring into a pure-play North American building products company is progressing, with the discontinued operations classification for AMES and the ONCAP joint venture on track, simplifying the business and reducing earnings noise. The Q3 performance directly addressed the key concern from the prior DeepValue report—that HBP adjusted EBITDA margin needed to return to at least 31% to validate durability—as margin expanded sequentially and year-over-year. Resilient repair and remodel demand, coupled with effective price/mix management, offset volume softness and cost pressures, indicating that the 30%+ margin target is achievable. With the simplification catalysts materializing and earnings power becoming clearer, the WAIT rating is no longer justified, and the thesis shifts toward a BUY as the valuation at 18.9x FY26 earnings offers reasonable entry despite trading above historical averages.

Implication

Investors who waited for margin durability and clarity on discontinued operations now have confirmation that HBP can sustain mid-30% EBITDA margins, making the bull case of $90+ per share more tangible. The ONCAP joint venture close and further asset sales will likely provide cash proceeds to reduce debt and fund buybacks, enhancing per-share value creation. The remaining business is simpler and more predictable, which should narrow the conglomerate discount and support a higher P/E multiple over time. However, risks remain from housing cycle sensitivity and potential customer concentration with Home Depot, so position sizing should reflect that. Overall, the risk-reward has tilted favorably, and a BUY rating with a target above $88 is warranted, with a trim level above $88 and attractive entry near $78-80.

Thesis delta

The prior WAIT rating hinged on proving that HBP margin could exceed 31% and that the portfolio simplification would not create unwanted charges. Q3 FY26 results show HBP margin rebounded strongly, and the restructuring is on schedule, thus upgrading the conviction from WAIT to BUY. The base case probability has increased, and the bear case of sub-$60 is now less likely.